Paxlovid Boceprevir Wapakatikati CAS 565456-77-1 Mayeso ≥99.0%
Zogulitsa Zamalonda PF-07321332 Paxlovid Zofananira Zogwirizana Ndi Ubwino Wapamwamba
L-tert-Leucine (H-Tle-OH) CAS 20859-02-3
Caronic Anhydride CAS 67911-21-1
(1R,2S,5S) -6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride 565456-77-1
Methyl (S) -2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS 328086-60-8
6,6-Dimethyl-3-azabicyclo[3.1.0]hexane CAS 943516-54-9
Dzina la Chemical | (1R,2S,5S) -6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride |
Mawu ofanana ndi mawu | Methyl (1R,2S,5S) -6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate Hydrochloride |
Nambala ya CAS | 565456-77-1 |
Nambala ya CAT | RF-PI318 |
Stock Status | Mu Stock, Kupanga Kukula Mpaka Matani |
Molecular Formula | Chithunzi cha C9H15NO2.ClH |
Kulemera kwa Maselo | 205.683 |
Mtundu | Ruifu Chemical |
Kanthu | Zofotokozera |
Maonekedwe | Ufa Woyera mpaka Woyera |
Chizindikiro A | IR: Zofanana ndi Reference Substance |
Chizindikiro B | Nthawi Yosungira: Zofanana ndi Zolozera |
Enantiomer | ≤0.15% |
Zoyipa Zogwirizana (zolemba ndi HPLC) | |
Chidetso Chosadziwika | ≤0.20% |
Zonse Zonyansa | ≤1.0% |
Madzi | ≤0.50% |
Zotsalira pa Ignition | ≤0.10% |
Zitsulo Zolemera | ≤20ppm |
Kuyesa | ≥99.0% |
Test Standard | Enterprise Standard |
Kugwiritsa ntchito | Wapakatikati wa PF-07321332 Paxlovid (CAS 2628280-40-8) ndi Boceprevir (CAS 394730-60-0) |
Phukusi: Botolo, Aluminiyamu zojambulazo thumba, makatoni ng'oma, 25kg / Drum, kapena malinga ndi zofuna za kasitomala.
Mkhalidwe Wosungira:Sungani muzitsulo zosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala, chinyezi ndi tizilombo towononga.
(1R,2S,5S) -6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride (CAS 565456-77-1) ndi yochokera ku azabicyclohexane yomwe imagwiritsidwa ntchito popanga matenda a chiwindi C. HIV (HCV) NS3 serine protease inhibitor.Ndilo lapakati la PF-07321332 Paxlovid (CAS 2628280-40-8) ndi Boceprevir (CAS 394730-60-0).PF-07321332 ndi yamphamvu komanso yogwira pakamwa ya SARS-CoV 3C-ngati protease (3CLPRO) inhibitor .PF-07321332 imayang'ana kachilombo ka SARS-CoV-2 ndipo itha kugwiritsidwa ntchito pofufuza kafukufuku wa COVID-19.Boceprevir (INN, trade name Victrelis) ndi protease inhibitor yomwe imagwiritsidwa ntchito ngati mankhwala a hepatitis C genotype 1. Imamanga ku HCV nonstructural 3 NS3 (HCV) yogwira ntchito.Inapangidwa ndi Schering-Plough, koma tsopano ikupangidwa ndi Merck kuyambira pamene Schering inapezedwa mu 2009. Inavomerezedwa ndi FDA pa May 13, 2011.